Skip to content

Estimating the Prevalence of GAstrocnemius Muscle REtraction in a Population Suffering From Plantar aPOneurositis and Describing the Effects of Lengthening

Estimating the Prevalence of GAstrocnemius Muscle REtraction in a Population Suffering From Plantar aPOneurositis and Describing the Effects of Lengthening

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07060352
Acronym
REGAPOP
Enrollment
100
Registered
2025-07-11
Start date
2025-09-01
Completion date
2029-03-01
Last updated
2025-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fasciitis

Brief summary

The gastrocnemius muscles, which form the upper part of the calf, can suffer from retraction, a common but often under-diagnosed condition, which can be a risk factor for plantar fasciitis. Retraction can be treated medically, by stretching, or surgically, by lengthening the muscles. Gastrocnemius retraction is difficult to measure, but tests such as the Ankle Dorsiflexion Index (ADI) provide a more accurate assessment. Knowing the prevalence of this retraction in patients suffering from plantar fasciitis would enable us to improve diagnostic criteria and better target treatments. Surgical lengthening of the gastrocnemius, particularly by tenotomy, is effective in cases of chronic plantar fasciitis, even without apparent muscle retraction.

Interventions

DIAGNOSTIC_TESTAnkle Dorsiflexion Index (ADI) measurement

Ankle Dorsiflexion Index (ADI) measurement at D0 and W8

Sponsors

Clinique Saint Charles
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patient aged 70 or under * Patient suffering from unilateral plantar fasciitis that has progressed for more than 6 months and is recalcitrant to medical treatment * Collection of express, oral consent * Available for follow-up visits

Exclusion criteria

* Patients with neuropathic pain * History of fracture of the lower limb, surgery on the lower limb, inflammatory rheumatism of the lower limb, injury to the Achilles tendon * Patient with another painful orthopedic lesion of the legs/feet * Patient with surgically treated plantar fasciitis in the year prior to inclusion * Persons unable to give consent * Not affiliated to a social security scheme * Persons under court protection * Participant in another study with an ongoing exclusion period

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of gastrocnemius muscle retraction in patients with plantar fasciitisAt Day 0retraction of the gastrocnemius muscles will be defined by an ADI of less than 13° measured by a digital inclinometer

Secondary

MeasureTime frameDescription
correlation between ADI measurement and pain Visual Analog Scale (VAS)At Day 0The VAS consists of a straight line where one extreme represents the total absence of pain and the other extreme, the most intense pain possible. Patients are asked to mark on this line the level of pain they feel at any given moment. Pain intensity is then measured according to the distance between the start of the scale (0) and the point where the patient placed his mark: * 0 cm (or the start of the scale): No pain * 10 cm (or the end of the scale): Maximum imaginable pain
Evolution of Visual Analog Scale (VAS)between Day 0 and Week 8The VAS consists of a straight line where one extreme represents the total absence of pain and the other extreme, the most intense pain possible. Patients are asked to mark on this line the level of pain they feel at any given moment. Pain intensity is then measured according to the distance between the start of the scale (0) and the point where the patient placed his mark: - 0 cm (or the start of the scale): No pain - 10 cm (or the end of the scale): Maximum imaginable pain
Evolution of Manchester Oxford Foot Questionnaire (MOXFQ)between Day 0 and Week 8The Manchester Oxford Foot Questionnaire (MOXFQ) is used to measure the impact of foot pain on patients' quality of life. It consists of 16 questions. The raw scores of the scales are converted into a metric scale ranging from 0 to 100, where 100 indicates the maximum intensity of suffering or limitation.
correlation between ADI measurement and Manchester Oxford Foot Questionnaire (MOXFQ)At Day 0The Manchester Oxford Foot Questionnaire (MOXFQ) is used to measure the impact of foot pain on patients' quality of life. It consists of 16 questions. The raw scores of the scales are converted into a metric scale ranging from 0 to 100, where 100 indicates the maximum intensity of suffering or limitation.
Correlation between surgical success and age of patientAt Day 0Surgical success is based on variation of pain (mesured with Visual Analogic Scale)
Correlation between surgical success and tobacco consumptionAt Day 0Surgical success is based on variation of pain (mesured with Visual Analogic Scale)
Correlation between surgical success and location of fasciitisAt Day 0Surgical success is based on variation of pain (mesured with Visual Analogic Scale) Location of fasciitis: proximal or central
Correlation between surgical success and body mass index (BMI)At Day 0Surgical success is based on variation of pain (mesured with Visual Analogic Scale)

Contacts

Primary ContactTimothée BISSUEL, MD
drtimothee.bissuel@gmail.com+334 78 27 07 97

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026